Evaluation of two management strategies for preoperative grade 1 endometrial cancer

Obstetrics and Gynecology

Volumn 114, Issue 1, 2009, Pages 7-15

  Bernardini, Marcus Q ^a   May, Taymaa ^b   Khalifa, Mahmoud A ^b   Bland, Amy E ^b   Nofech mozes, Sharon ^b   Berchuck, Andrew ^b   Covens, Al ^b   Havrilesky, Laura ^b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; CANCER CENTER; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HUMAN; HYSTERECTOMY; LAPAROSCOPIC SURGERY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VAGINAL HYSTERECTOMY;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 67651034277     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181aa97fc     Document Type: Article

References (24)

1. Creasman WT, Morrow CP, Bundy BN, Homesley HD, GrahamJE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987;60:2035-41.
2. Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 2000;182: 1506-19.
3. Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojin F, et al. 3rd Adenocarcinoma of the endome-trium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995;56:29-33.
4. Larson DM, Broste SK, Krawisz BR. Surgery without radiotherapy for primary treatment of endometrial cancer. Obstet Gynecol 1998;91:355-9.
5. Podczaski E, Kaminski P, Gurski K, MacNeill C, Stryker JA, Singapuri K, et al. Detection and patterns of treatment failure in 300 consecutive cases of "early" endometrial cancer after primary surgery. Gynecol Oncol 1992;47:323-7.
6. Chan JK, Wu H, Cheung MK, Shin JY, Osann K, Kapp DS. The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecol Oncol 2007;106:282-8.
7. Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT, et al. Retrospective analysis of selective lymphade-nectomy in apparent early-stage endometrial cancer. J Clin Oncol 2005;23:3668-75.
8. Lutman CV, Havrilesky LJ, Cragun JM, Secord AA, Calingaert B, Berchuck A, et al. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endo-metrial carcinoma with high-risk histology. Gynecol Oncol 2006;102:92-7.
9. Carney M, Lancaster JM, Ford C, Tsodikov A, Wiggins CL. A population-based study of patterns of care for endometrial cancer: who is seen by a gynecologic oncologist and who is not? Gynecol Oncol 2002;84:36-42.
10. KwonJS, Carey MS, Cook EF, Qiu F, Paszat LF. Addressing wait times for endometrial cancer surgery in Ontario. J Obstet Gynaecol Can 2007;29:982-7.
11. Kwon JS, Carey MS, Goldie SJ, Kim JJ. Cost-effectiveness analysis of treatment strategies for Stage I and II endometrial cancer. J Obstet Gynaecol Can 2007;29:131-9.
12. Cohn DE, Huh WK, Fowler JM, Straughn JM Jr. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma. Obstet Gynecol 2007;109:1388-95.
13. Havrilesky LJ, Maxwell GL, Chan JK, Myers ER. Cost effecttiveness of a test to detect metastases for endometrial cancer. Gynecol Oncol 2009;112:526-30.
14. Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 1980;56:419-27.
15. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000;355:1404-11.
16. Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study [published erratum appears in Gynecol Oncol 2004;94:241-2]. Gynecol Oncol 2004;92:744-51.
17. Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 2008;109:11-8.
18. Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, et al. Systematic pelvic lymphade-nectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008; 100:1707-16.
19. ASTEC/EN.5 Study Group, Blake P, Swart AM, Orton J, Kitchener H, Whelan T, Lukka H, et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet 2009;373:137-46.
20. ASTEC study group, Kitchener H, Swart AM, Qian Q Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenec-tomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009;373:125-36.
21. Abu-Rustum NR, Alektiar K, Iasonos A, Lev G, Sonoda Y, Aghajanian C, et al. The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Ketter-ing Cancer Center. Gynecol Oncol 2006;103:714-8.
22. Jewell EL, Kulasingam S, Myers ER, Alvarez Secord A, Havrilesky LJ. Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis. Gynecol Oncol 2007;107:532-40.
23. Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J, et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 2006;24:36-44.
24. Susumu N, Sagae S, Udagawa Y, Niwa K, Kuramoto H, Satoh S, et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol 2008;108:226-33.